Reinsurance firm SCOR Global Life has joined forces with Human Longevity (HLI) to offer data-driven health intelligence to life insurance customers.
The alliance will offer SCOR Global Life clients access to HLI’s health information services.
SCOR Global Life executive vice president and chief strategy officer in the Americas Michael Colannino said: “As data-driven health intelligence becomes more accessible and affordable, we see an opportunity to improve the health and well-being of policyholders by offering services that can help extend life expectancy.
“As a reinsurer, we are eager to contribute to innovation that identifies health risks early and provides win-win outcomes.”
HLI makes health assessments leveraging DNA sequencing, expert analysis, data intelligence, and machine learning.
The firm takes insights from tests such as full genome sequencing, MRI, and blood samples to prepare health risk profile of users.
The aim is to decrease or postpone the onset of certain conditions, and raise the life expectancy of consumers aged over 50 years by five to ten years.
HLI interim CEO and chief of radiogenomics David Karow said: “We believe our partnership with SCOR Global Life will demonstrate the potential for these predictive models to improve risk management capabilities for the life insurance and reinsurance industries, with an even more inspiring benefit in the potential it has to help their clients live longer and healthier lives.”